Oxyfedrine, a new anti-anginal drug with a unique mode of action, was compared with placebo and oxprenolol in thirty patients with stable angina pectoris. Total exercise time and exercise time to onset of angina was significantly improved, compared to placebo and was comparable to that produced by oxprenolol. Heart rate and blood pressure were not affected. Side effects were few.